Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Te‐Shien Kung"'
Autor:
Ruei‐Yu He, Xiang‐Me Lai, Chia‐Sui Sun, Te‐Shien Kung, Jhu‐Ying Hong, Yu‐Song Jheng, Wei‐Neng Liao, Jen‐Kun Chen, Yung‐Feng Liao, Pang‐Hsien Tu, Joseph Jen‐Tse Huang
Publikováno v:
Advanced Science, Vol 7, Iss 2, Pp n/a-n/a (2020)
Abstract Finding an effective therapeutic regimen is an urgent demand for various neurodegenerative disorders including Huntington's disease (HD). For the difficulties in observing the dynamic aggregation and oligomerization process of mutant Hunting
Externí odkaz:
https://doaj.org/article/ea4bbab767c443acb71235cffdefc1b7
Autor:
Te-shien Kung, 孔德賢
101
In our study, we intended to test the potential therapeutic strategy based on a novel bipartite peptide design including non-pathogenic polyQ and polyR. We have successfully synthesized 10 different polyQ-based peptides with >95% purity as e
In our study, we intended to test the potential therapeutic strategy based on a novel bipartite peptide design including non-pathogenic polyQ and polyR. We have successfully synthesized 10 different polyQ-based peptides with >95% purity as e
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/5gecde
Autor:
Yung‐Feng Liao, Te‐Shien Kung, Yu‐Song Jheng, Pang-Hsien Tu, Chia-Sui Sun, Wei‐Neng Liao, Ruei-Yu He, Jen‐Kun Chen, Joseph Jen-Tse Huang, Jhu‐Ying Hong, Xiang-Me Lai
Publikováno v:
Advanced Science, Vol 7, Iss 2, Pp n/a-n/a (2020)
Advanced Science
Advanced Science
Finding an effective therapeutic regimen is an urgent demand for various neurodegenerative disorders including Huntington's disease (HD). For the difficulties in observing the dynamic aggregation and oligomerization process of mutant Huntingtin (mHtt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0c7641f209762b60986b81669b06378
https://doi.org/10.1002/advs.201901165
https://doi.org/10.1002/advs.201901165